Back to Stocks
Stock detail
Gilead Sciences, Inc.
GILDSTOCKS | US | NASDAQ | Healthcare | Drug Manufacturers - General
Profile snapshotUSD 134.3Market cap USD 166.8B
No local candle data found.
Recent detected patterns / setups
Latest 10 Market Radar results for this symbol.
PatternTFDetectedQuality
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishFVG Reaction Setup15M + 15M28 Jul 26, 15:4595
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishFVG Reaction Setup15M + 15M28 Jul 26, 15:4595
BullishOrder Block Setup4H28 Jul 26, 13:3068
BullishFVG Reaction Setup4H + 15M28 Jul 26, 15:4599
BullishOrder Block Setup4H28 Jul 26, 13:3068
BullishFVG Reaction Setup4H + 15M28 Jul 26, 15:4599
BullishMA 8/21 Crossover1D28 Jul 26, 00:0065
BullishMA 21/55 Crossover1D28 Jul 26, 00:0080
Annual
Annual fundamentals
2025 vs previous annual period
Metric202020212022202320242025
Total revenueUSD 24.7B+10.0%USD 27.3B+10.6%USD 27.3B-0.1%USD 27.1B-0.6%USD 28.8B+6.0%USD 29.4B+2.4%
Net incomeUSD 123M-97.7%USD 6.2B+4961.0%USD 4.6B-26.2%USD 5.7B+23.4%USD 480M-91.5%USD 8.5B+1672.9%
Net profit margin0.5%-97.9%22.8%+4476.1%16.8%-26.2%20.9%+24.1%1.7%-92.0%28.9%+1631.5%
EPS0.1-97.7%4.96+4966.4%3.66-26.2%4.54+24.0%0.38-91.6%6.84+1700.0%
Quarterly
Quarterly fundamentals
Q1 2026 vs same quarter previous year
MetricQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total revenueUSD 7.6B+6.4%USD 6.7B-0.3%USD 7.1B+1.8%USD 7.8B+3.0%USD 7.9B+4.7%USD 7B+4.4%
Net incomeUSD 1.8B+24.8%USD 1.3B+131.5%USD 2B+21.4%USD 3.1B+143.6%USD 2.2B+22.4%USD 2B+53.7%
Net profit margin23.6%+17.3%19.7%+131.6%27.7%+19.2%39.3%+136.6%27.5%+16.9%29.0%+47.2%
EPS1.43+24.3%1.06+131.7%1.57+21.7%2.46+146.0%1.76+23.1%1.63+53.8%
Ownership
Institutional ownership summary
2026 Q2, quarter ended 2026-06-30
PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call
2026 Q22026-06-30